Blog / Archives
Biotech Vaults Back with help from Array Biopharma…Update-2…Not a lotta
Update-2...3:15p EDT.... Mixed day-new post after close, XBI down 0.64%, IBB down 0.94%,, Dow sell-off down 0.43%. ====== Update-1 5/22... Not much follow-through from yesterday but trade-able.A...
ASCO Rally Fizzles: The nascent rally in biotech stocks fades.Update-2
Update-2...NASDAQ Rally triggers biotechs-XBI up 2.3% to $82.63 just above 2019 support level.Administration eased Huawei blocks because of trade concerns. Update -1 ...11a EDT-Biotech Red...
Bad Week in Biotech: Deciphering the Damage…Update-3 5/16 ASCO rally
Update-3 12:30 P EDT ASCO Rally seems too be kicking in.Green Screen! Update-2 5/15 10;45a EDT Gene therapy and mid-cap biopharma getting traction this am.XBI up 0.7% to $82.44. Update-1 5/14 3:30P...
Biotech Week Ending May 4: Choppy Action Persists-Risk Off…Update-3
Traders -look for a turnaround in small cap biopharma and medtech today. NAZ at 7890. 5/10 1:30p EDT....Well we know now that even biotech stocks are not immune to tariffs. Risk off. Major ETFS IBB...
Biopharma Wrap-Up Q1 2019: Large Caps Lag Since August 2018
Biopharma Wrap-Up: Sideways to Neutral in Active Trading for Quarter Biopharma stocks ended the quarter in a snooze as investors took a wait and see attitude as earnings roll-out for large caps. The...
Large Cap Biopharma Performance and Valuations 4/28/19
Large Cap Biopharma Stocks: Performance and Valuations for 2019. In 2019 the IBB was a less risky pick for a biopharma portfolio; ABBV and BMY look good. Merck (MRK) and Vertex (VRTX) were the top...
Large Cap Biopharma Stocks Performance 2019: Interim Report 4/25
Large Cap Biopharma Stocks Review Ongoing Through Q1 Earnings Small and Mid-Caps Outperform Large Caps YTD: XBI up 21 % YTD vs IBB up 8.19% QQQ up 27%. Rally emerging today on oversold condition in...
Biotech Wreck: What To Look For Next…Update-3 earnings reports
Update-3 XLV up from bottom at $86 to $88.63. IBB holding but more choppy at $107 level. Update-2 12p EDT-IBB flattish at $106 as earnings on large caps come in-will be reviewed at end of week....
Choppy Week in Healthcare with Drug Pricing Issues Yet Again: Update-2-SELL-OFF
Update-2 10:45a 4/17...XBI down 3.37% to FEB support at $86. Healthcare issues are spilling over to biotech.Red screen day and all biotechs hit very hard.Drug pricing models are under scrutiny....
Biotech Hits New Highs for 2019:The Trends are Bullish…Update-3 at Sell-Off
4/11 ALERT: Need to check out reasons for biotech sell-off; could be proposed drug pricing bills and "affordability board." See STAT News . See 4/11 chart below for XBI. Choppy pattern returns at...